<SEC-DOCUMENT>0001144204-17-057823.txt : 20171109
<SEC-HEADER>0001144204-17-057823.hdr.sgml : 20171109
<ACCEPTANCE-DATETIME>20171109170937
ACCESSION NUMBER:		0001144204-17-057823
CONFORMED SUBMISSION TYPE:	S-4/A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20171109
DATE AS OF CHANGE:		20171109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		S-4/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-219898
		FILM NUMBER:		171191825

	BUSINESS ADDRESS:	
		STREET 1:		700 NORTH BRAND BLVD.,
		STREET 2:		SUITE 1400
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203
		BUSINESS PHONE:		818-839-5200

	MAIL ADDRESS:	
		STREET 1:		700 NORTH BRAND BLVD.,
		STREET 2:		SUITE 1400
		CITY:			GLENDALE
		STATE:			CA
		ZIP:			91203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-4/A
<SEQUENCE>1
<FILENAME>tv479112_s4a.htm
<DESCRIPTION>AMENDMENT NO. 3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>As filed with the Securities and
Exchange Commission on November 9, 2017</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Registration No. 333-219898</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <B>AMENDMENT NO. 3</B> </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM S-4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REGISTRATION STATEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNDER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">THE SECURITIES ACT OF 1933</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 16pt"><B>APOLLO
MEDICAL HOLDINGS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in
its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Delaware</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(State or Other Jurisdiction of</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Incorporation or Organization)</P></TD>
    <TD STYLE="width: 2%; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>8742</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Primary Standard Industrial</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Classification Code Number)</P></TD>
    <TD STYLE="width: 2%; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>20-8046599</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(I.R.S. Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Identification Number)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">700 N. Brand Blvd., Suite 1400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Glendale, CA 91203</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(818) 396-8050</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address, Including Zip Code, and Telephone
Number,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Including Area Code, of Registrant&rsquo;s
Principal Executive Offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warren Hosseinion, M.D.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Executive Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Apollo Medical Holdings, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>700 N. Brand Blvd., Suite 1400</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Glendale, CA 91203</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(818) 396-8050</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name, address, including zip code, and
telephone<BR>
number, including area code, of agent for service)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Copies to:</I></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Mark Mihanovic, Esq.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Paul Carr-Rollitt, Esq.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Gary Emmanuel, Esq.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>McDermott Will &amp; Emery LLP</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2049 Century Park East, 38<SUP>th</SUP>
        Floor</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Los Angeles, CA 90067</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(310) 277-4110</B></P></TD>
    <TD STYLE="width: 2%; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Thomas Lam, M.D.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Chief Executive Officer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Network Medical Management, Inc.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1668 S. Garfield Avenue</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Alhambra, CA 91801</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(626) 282-0288</B></P></TD>
    <TD STYLE="width: 2%; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tin Kin Lee, Esq.</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Tin Kin Lee Law Offices</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>1811 Fair Oaks Avenue</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>South Pasadena, CA 91030</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(626) 229-9828</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Approximate date of commencement of
proposed sale to the public:</B> As soon as practicable after this Registration Statement is declared effective and all other conditions
to the transaction contemplated by the Agreement and Plan of Merger, dated as of December 21, 2016, as amended on March 30, 2017
and October 17, 2017, described in the enclosed joint proxy statement/prospectus have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the securities being registered on this
Form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G,
check the following box. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If this Form is a post-effective amendment
filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement
number of the earlier effective registration statement for the same offering. <FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth
company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer,&rdquo; &ldquo;smaller reporting
company&rdquo; and &ldquo;emerging growth company&rdquo; in Rule 12b-2 of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Large accelerated filer <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD>
    <TD STYLE="width: 40%; font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Accelerated filer <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Non-accelerated filer <FONT STYLE="font-family: Wingdings">&uml;</FONT> (Do not check if a smaller reporting company)</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Smaller reporting company <FONT STYLE="font-family: Wingdings">x</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><FONT STYLE="font-size: 10pt">Emerging Growth company <FONT STYLE="font-family: Wingdings">&uml;</FONT></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 9pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If applicable, place an X in the box to
designate the appropriate rule provision relied upon in conducting this transaction:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt"><FONT STYLE="font-size: 10pt">Exchange Act Rule 13e-4(i) (Cross-Border Issuer Tender Offer)</FONT></TD>
    <TD STYLE="width: 40%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Exchange Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&uml;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registrant hereby amends this registration
statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment
which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the registration statement shall become effective on such date as the Securities and Exchange
Commission, acting pursuant to said Section 8(a), may determine.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> Explanatory Note </P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> &nbsp; </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15pt; text-align: justify"> Apollo Medical Holdings,
Inc. (the &ldquo;Registrant&rdquo;) is filing this Amendment No. 3 (the &ldquo;Amendment&rdquo;) to its Registration Statement
on Form S-4 (Registration Statement No. 333-219898) as an exhibits-only filing to file Exhibit 8.1 and restate the list of exhibits
set forth in Item 8 of Part II of the Registration Statement. Accordingly, this Amendment consists only of the facing page, this
explanatory note, Part II of the Registration Statement, including the signature page and the exhibit index, and the filed exhibit.
The prospectus is unchanged and has been omitted. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PART II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INFORMATION NOT REQUIRED IN JOINT PROXY
STATEMENT/PROSPECTUS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>Item 20.</B></TD><TD STYLE="text-align: justify"><B>Indemnification of Directors and Officers</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">ApolloMed is a Delaware
corporation. Reference is made to Section 102(b)(7) of the Delaware General Corporation Law, which enables a corporation in its
original certificate of incorporation or an amendment thereto to eliminate or limit the personal liability of a director for violations
of the director&rsquo;s fiduciary duty, except (1) for any breach of the director&rsquo;s duty of loyalty to the corporation or
its stockholders, (2) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of
law, (3) pursuant to Section 174 of the Delaware General Corporation Law (providing for liability of directors for unlawful payment
of dividends or unlawful stock purchase or redemptions) or (4) for any transaction from which a director derived an improper personal
benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Reference also is made
to Section 145 of the Delaware General Corporation Law, which provides that a corporation may indemnify any persons, including
officers and directors, who are, or are threatened to be made, parties to any threatened, pending or completed legal action, suit
or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of such corporation),
by reason of the fact that such person was an officer, director, employee or agent of such corporation or is or was serving at
the request of such corporation as a director, officer, employee or agent of another corporation or enterprise. The indemnity may
include expenses (including attorney&rsquo;s fees), judgments, fines and amounts paid in settlement actually and reasonably incurred
by such person in connection with such action, suit or proceeding, provided such officer, director, employee or agent acted in
good faith and in a manner he reasonably believed to be in or not opposed to the corporation&rsquo;s best interest and, for criminal
proceedings, had no reasonable cause to believe that his conduct was unlawful. A Delaware corporation may indemnify officers and
directors in an action by or in the right of the corporation under the same conditions, except that no indemnification is permitted
without judicial approval if the officer or director is adjudged to be liable to the corporation. Where an officer or director
is successful on the merits or otherwise in the defense of any action referred to above, the corporation must indemnify him against
the expenses that such officer or director actually and reasonably incurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ApolloMed Bylaws
allow for, and the ApolloMed Charter provides for, indemnification of ApolloMed&rsquo;s current and former directors, officers,
committee members or representatives to the full extent permitted by Delaware law. ApolloMed has an existing Directors and Officers
Insurance Policy that provides coverage for its directors and officers in certain situations. ApolloMed has also entered into indemnification
agreements with its directors and executive officers, in addition to the indemnification provided for in the ApolloMed Charter
and ApolloMed Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>Item 21.</B></TD><TD STYLE="text-align: justify"><B>Exhibits and Financial Statements</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>(a) Exhibit Index</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A list of exhibits filed with this registration
statement on Form S-4 is set forth on the Exhibit Index and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B><I>(b) Financial Statements</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The financial statements filed with this
registration statement on Form S-4 are set forth on the Financial Statement Index and is incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in; text-align: left"><B>Item 22.</B></TD><TD STYLE="text-align: justify"><B>Undertakings</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned registrant hereby undertakes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.9in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the registration statement.&nbsp; Notwithstanding the foregoing, any increase or decrease in volume of securities offered
(if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange
Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change
in the maximum aggregate offering price set forth in the &ldquo;Calculation of Registration Fee&rdquo; table in the effective registration
statement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.9in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.9in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That,
for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(3)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
undersigned registrant hereby undertakes as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That
prior to any public reoffering of the securities registered hereunder through use of a proxy statement/prospectus/information statement
which is a part of this registration statement, by any person or party who is deemed to be an underwriter within the meaning of
Rule&nbsp;145(c), the issuer undertakes that such reoffering proxy statement/prospectus/information statement will contain the
information called for by the applicable registration form with respect to reofferings by persons who may be deemed underwriters,
in addition to the information called for by the other items of the applicable form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(2)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;That every proxy statement/prospectus (i)&nbsp;that
is filed pursuant to paragraph (b)(1) immediately preceding, or (ii)&nbsp;that purports to meet the requirements of Section&nbsp;10(a)(3)
of the Securities Act and is used in connection with an offering of securities subject to Rule&nbsp;415, will be filed as a part
of an amendment to the registration statement and will not be used until such amendment is effective, and that, for purposes of
determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
initial bona fide offering thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(3)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To respond to requests for information that is incorporated
by reference into this proxy statement/prospectus/information statement pursuant to Item 4 10(b), 11, or 13 of this Form, within
one business day of receipt of such request, and to send the incorporated documents by first class mail or other equally prompt
means. This includes information contained in documents filed subsequent to the effective date of the registration statement through
the date of responding to the request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">(4)
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To supply by means of a post-effective
amendment all information concerning a transaction, and the company being acquired involved therein, that was not the subject of
and included in the registration statement when it became effective.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant
of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,
the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Si<A NAME="a_033"></A>gnatures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> Pursuant to the
requirements of the Securities Act of 1933, as amended, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in the city of Glendale, State of California, on the 9<SUP>th</SUP>
day of November, 2017. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>APOLLO MEDICAL HOLDINGS, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;/s/ Warren Hosseinion, M.D.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><B>Warren Hosseinion, M.D.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><B><I>Chief Executive Officer </I></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 4in"><B><I>&nbsp;&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Act of 1933, as amended, this registration statement has been signed below by the following persons on behalf of the registrant
and in the capacities and on the dates indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 24%; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Signature</B></FONT> </TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; width: 48%; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Title</B></FONT> </TD>
    <TD STYLE="vertical-align: top; width: 2%; text-align: center"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; width: 24%; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Date</B></FONT> </TD></TR>
<TR>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top; text-align: center"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">/s/ Warren
    Hosseinion, M.D.</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Chief Executive Officer and Director</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> <FONT STYLE="font-size: 10pt">November 9, 2017</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Warren Hosseinion, M.D.</B></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt"><I>(Principal Executive Officer)</I></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">/s/ Mihir
    Shah</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Chief Financial Officer</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> <FONT STYLE="font-size: 10pt">November 9, 2017</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Mihir Shah</B></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt"><I>(Principal Financial Officer and Principal Accounting
    Officer)</I></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">*</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Executive Chairman and Director</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> <FONT STYLE="font-size: 10pt">November 9, 2017</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Gary Augusta</B></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">*</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> <FONT STYLE="font-size: 10pt">November 9, 2017</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Mark Fawcett</B></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">*</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> <FONT STYLE="font-size: 10pt">November 9, 2017</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Suresh Nihalani</B></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">*</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> <FONT STYLE="font-size: 10pt">November 9, 2017</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-size: 10pt"><B>David Schmidt</B></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">*</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> <FONT STYLE="font-size: 10pt">November 9, 2017</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Thomas Lam, M.D.</B></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="text-align: center"> &nbsp; </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"> <FONT STYLE="font-size: 10pt">*</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> <FONT STYLE="font-size: 10pt">Director</FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> <FONT STYLE="font-size: 10pt">November 9, 2017</FONT> </TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: center"> <FONT STYLE="font-size: 10pt"><B>Ted Schreck</B></FONT> </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom"> &nbsp; </TD>
    <TD STYLE="vertical-align: top"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; text-align: center"> &nbsp; </TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="width: 5%"><FONT STYLE="font-size: 10pt">* By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><U STYLE="text-decoration: none">/s/ Warren Hosseinion, M.D.</U></FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Warren Hosseinion</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Attorney-in-fact</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit Index</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 9%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
    <FONT STYLE="font-size: 10pt"><B>No.</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 90%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm">
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&dagger;*</FONT> </A></TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm">
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement and Plan of Merger, dated December
    21, 2016, among Apollo Medical Holdings, Inc., Network Medical Management, Inc., Apollo Acquisition Corp. and Kenneth Sim,
    M.D. (attached as&nbsp;<U>Annex A</U>&nbsp;to the joint proxy statement/prospectus that is a part of this Registration Statement).
    </FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2*</FONT> </A></TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Agreement and Plan of Merger, dated
    March 30, 2017, among Apollo Medical Holdings, Inc., Network Medical Management, Inc., Apollo Acquisition Corp. and Kenneth
    Sim, M.D. (attached as&nbsp;<U>Annex A</U>&nbsp;to the joint proxy statement/prospectus that is a part of this Registration
    Statement).</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit">
    2.3* </A></TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit">
    Amendment No. 2 to Agreement and Plan of Merger, dated October 17, 2017, among Apollo Medical Holdings, Inc., Network Medical
    Management, Inc., Apollo Acquisition Corp. and Kenneth Sim, M.D. (attached as&nbsp;<U>Annex A</U>&nbsp;to the joint proxy
    statement/prospectus that is a part of this Registration Statement). </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415002897/v398912_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415002897/v398912_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated
    Certificate of Incorporation (filed as an exhibit to a Current Report on Form 8-K on January 21, 2015).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415025170/v408340_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415025170/v408340_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Amendment to Restated Certificate of Incorporation (filed as an exhibit to a Current Report on Form 8-K on April 27, 2015).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415059991/v422440_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415059991/v422440_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificate
    of Designation of Series A Convertible Preferred Stock (filed as an exhibit to a Current Report on Form 8-K on October 19,
    2015).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex3-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated Certificate of Designation of Apollo Medical Holdings, Inc. (filed as an exhibit to a Current Report on Form
    8-K on April 4, 2016).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415066090/v423843_ex3-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415066090/v423843_ex3-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated
    Bylaws (filed as an exhibit to a Quarterly Report on Form 10-Q on November 16, 2015).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420412068108/v330006_ex4-4.htm" STYLE="-sec-extract: exhibit">4.<FONT STYLE="font-size: 10pt">1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420412068108/v330006_ex4-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form
    of Investor Warrant, dated October 29, 2012, for the purchase of common stock (filed as an exhibit to a Quarterly Report on
    Form 10-Q on December 17, 2012).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413025748/v340341_ex4-6.htm" STYLE="-sec-extract: exhibit">4.<FONT STYLE="font-size: 10pt">2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413025748/v340341_ex4-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form
    of 9% Senior Subordinated Callable Convertible Note, dated January 31, 2013 (filed as an exhibit to an Annual Report on Form
    10-K on May 1, 2013).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413025748/v340341_ex4-7.htm">4.<FONT STYLE="font-size: 10pt">3</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413025748/v340341_ex4-7.htm"><FONT STYLE="font-size: 10pt">Form
    of Investor Warrant for purchase of 3,750 shares of common stock, dated January 31, 2013 (filed as an exhibit to an Annual
    Report on Form 10-K on May 1, 2013).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex4-1.htm" STYLE="-sec-extract: exhibit">4.<FONT STYLE="font-size: 10pt">4</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Common
    Stock Purchase Warrant dated October 14, 2015, issued by Apollo Medical Holdings, Inc. to Network Medical Management, Inc.
    to purchase 1,111,111 shares of common stock (filed as an exhibit to a Current Report on Form 8-K on April 4, 2016).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex4-1.htm" STYLE="-sec-extract: exhibit">4.<FONT STYLE="font-size: 10pt">5</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Common
    Stock Purchase Warrant dated March 30, 2016, issued by Apollo Medical Holdings, Inc. to Network Medical Management, Inc. to
    purchase 555,555 shares of common stock (filed as an exhibit to a Current Report on Form 8-K on April 4, 2016).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416133045/v452465_ex4-1.htm" STYLE="-sec-extract: exhibit">4.<FONT STYLE="font-size: 10pt">6</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416133045/v452465_ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Common
    Stock Purchase Warrant dated November 4, 2016 issued by Apollo Medical Holdings, Inc., to Scott Enderby to purchase 24,000
    shares of common stock (filed as an exhibit to a Current Report on Form 8-K on November 10, 2016).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417009037/v459268_ex4-1.htm" STYLE="-sec-extract: exhibit">4.<FONT STYLE="font-size: 10pt">7</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417009037/v459268_ex4-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Common
    Stock Purchase Warrant dated November 17, 2016 issued by Apollo Medical Holdings, Inc. to Liviu Chindris, M.D. (filed as an
    exhibit to a Quarterly Report on Form 10-Q on February 14, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit">
    4.<FONT STYLE="font-size: 10pt">8*</FONT> </A></TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">Form of Warrant to be Issued as Merger Consideration (attached as&nbsp;Annex C&nbsp;to the
    joint proxy statement/prospectus that is a part of this Registration Statement).</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex5-1.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">5.1*</FONT> </A></TD>
    <TD> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex5-1.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">Opinion of McDermott Will &amp; Emery LLP regarding the validity of the securities.</FONT>
    </A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; text-align: center"> <A HREF="tv479112_ex8-1.htm" STYLE="-sec-extract: exhibit"> 8.1# </A></TD>
    <TD STYLE="width: 1%"> &nbsp; </TD>
    <TD STYLE="width: 90%; text-align: justify"> <A HREF="tv479112_ex8-1.htm" STYLE="-sec-extract: exhibit"> Opinion of
    McDermott Will &amp; Emery LLP regarding tax matters. </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420408035957/v117758_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420408035957/v117758_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement
    and Plan of Merger among Siclone Industries, Inc. and Apollo Acquisition Co., Inc. and Apollo Medical Management, Inc. (filed
    as an exhibit to a Current Report on Form 8-K on June 19, 2008).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420410045126/v194384_def14c.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420410045126/v194384_def14c.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2010
    Equity Incentive Plan (filed as Appendix A to Schedule 14C Information Statement filed on August 17, 2010).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420412017520/v307090_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420412017520/v307090_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    of Directors Agreement dated March 22, 2012, by and between Apollo Medical Holdings, Inc. and Suresh Nihalani (filed as an
    exhibit to an Annual Report on Form 10-K/A on March 28, 2012).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-13.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-13.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2013
    Equity Incentive Plan&nbsp;of Apollo Medical Holdings, Inc. dated April 30, 2013 (filed as an exhibit to an Annual Report
    on Form 10-K on May 8, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-14.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-14.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    of Directors Agreement dated May 22, 2013 by and between Apollo Medical Holdings, Inc., and David Schmidt (filed as an exhibit
    to an Annual Report on Form 10-K on May 8, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413034837/v345926_ex10-17.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413034837/v345926_ex10-17.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intercompany
    Revolving Loan Agreement, dated February 1, 2013, by and between Apollo Medical Management, Inc. and Maverick Medical Group,
    Inc. (filed as an exhibit to a Quarterly Report on Form 10-Q on June 14, 2013).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413050838/v354222_ex10-19.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413050838/v354222_ex10-19.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intercompany
    Revolving Loan Agreement, dated July 31, 2013 by and between Apollo Medical Management, Inc. and ApolloMed Care Clinic (filed
    as an exhibit to a Quarterly Report on Form 10-Q on September 16, 2013).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415003002/v399081_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415003002/v399081_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting
    and Representation Agreement between Flacane Advisors, Inc. and Apollo Medical Holdings, Inc., dated January 15, 2015 (filed
    as an exhibit to a Current Report on Form 8-K on January 21, 2015).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413068393/v361888_ex10-22.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413068393/v361888_ex10-22.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intercompany
    Revolving Loan Agreement dated as of September 30, 2013, between Apollo Medical Management, Inc. and ApolloMed Hospitalists,
    a Medical Corporation (filed as an exhibit to a Quarterly Report on Form 10-Q on December 20, 2013).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413068976/v363896_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420413068976/v363896_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
    of Settlement Agreement and Release, between Apollo Medical Holdings, Inc. and each of the Holders listed on Exhibit A to
    the First Amendment, effective December 20, 2013 (filed as an exhibit to a Current Report on Form 8-K on December 24, 2013).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit
    Agreement, between Apollo Medical Holdings, Inc. and NNA of Nevada, Inc., dated March 28, 2014 (filed as an exhibit to a Current
    Report on Form 8-K on March 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investment
    Agreement, between Apollo Medical Holdings, Inc. and NNA of Nevada, Inc., dated March 28, 2014 (filed as an exhibit to a Current
    Report on Form 8-K on March 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-8.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-8.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collateral
    Assignment of Physician Shareholder Agreement and Management Agreement, among Apollo Medical Holdings, Inc., Apollo Medical
    Management, Inc., and NNA of Nevada, Inc., dated March 28, 2014 (acknowledged by ApolloMed Care Clinic, and Warren Hosseinion,
    M.D.) (filed as an exhibit to a Current Report on Form 8-K on March 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-9.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-9.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collateral
    Assignment of Physician Shareholder Agreement and Management Agreement, among Apollo Medical Holdings, Inc., Apollo Medical
    Management, Inc., and NNA of Nevada, Inc., dated March 28, 2014 (acknowledged by Maverick Medical Group Inc. and Warren Hosseinion,
    M.D.) (filed as an exhibit to a Current Report on Form 8-K on March 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-10.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-10.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Collateral
    Assignment of Physician Shareholder Agreement and Management Agreement, among Apollo Medical Holdings, Inc., Apollo Medical
    Management, Inc., and NNA of Nevada, Inc., dated March 28, 2014 (acknowledged by ApolloMed Hospitalists and Warren Hosseinion,
    M.D.) (filed as an exhibit to a Current Report on Form 8-K on March 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-11.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-11.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
    Agreement, among Apollo Medical Holdings, Inc., Warren Hosseinion, M.D., Adrian Vazquez, M.D., and NNA of Nevada, Inc., dated
    March 28, 2014 (filed as an exhibit to a Current Report on Form 8-K on March 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-12.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414018959/v373196_ex10-12.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration
    Rights Agreement, between Apollo Medical Holdings, Inc. and NNA of Nevada, Inc., dated March 28, 2014 (filed as an exhibit
    to a Current Report on Form 8-K on March 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-15.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-15.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hospitalist
    Participation Service Agreement, between ApolloMed Hospitalists and Warren Hosseinion, M.D., dated March 28, 2014 (filed as
    an exhibit to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-16.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hospitalist
    Participation Service Agreement, between ApolloMed Hospitalists and Adrian Vazquez, M.D., dated March 28, 2014 (filed as an
    exhibit to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-17.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-17.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Option Agreement, between Warren Hosseinion, M.D. and Apollo Medical Holdings, Inc., dated March 28, 2014 (filed as an exhibit
    to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-18.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-18.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Option Agreement, between Adrian Vazquez, M.D. and Apollo Medical Holdings, Inc., dated March 28, 2014 (filed as an exhibit
    to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-19.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-19.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated Management Services Agreement, between Apollo Medical Management, Inc. and ApolloMed Care Clinic, dated March
    28, 2014 (filed as an exhibit to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-20.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-20.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated Management Services Agreement, between Apollo Medical Management, Inc. and Maverick Medical Group Inc., dated
    March 28, 2014 (filed as an exhibit to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-21.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></A></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 90%; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-21.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
    and Restated Management Services Agreement, between Apollo Medical Management, Inc. and ApolloMed Hospitalists, dated March
    28, 2014 (filed as an exhibit to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-22.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-22.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Physician
    Shareholder Agreement, granted and delivered by Warren Hosseinion, M.D., in favor of Apollo Medical Management, Inc. and Apollo
    Medical Holdings, Inc., for the account of ApolloMed Care Clinic, dated March 28, 2014 (filed as an exhibit to a Current Report
    on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-23.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-23.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Physician
    Shareholder Agreement, granted and delivered by Warren Hosseinion, M.D., in favor of Apollo Medical Management, Inc. and Apollo
    Medical Holdings, Inc., for the account of Maverick Medical Group, Inc., dated March 28, 2014 (filed as an exhibit to a Current
    Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-24.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-24.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Physician
    Shareholder Agreement, granted and delivered by Warren Hosseinion, M.D., in favor of Apollo Medical Management, Inc. and Apollo
    Medical Holdings, Inc., for the account of ApolloMed Hospitalists, dated March 28, 2014 (filed as an exhibit to a Current
    Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-25.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-25.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    No. 1 to Intercompany Revolving Loan Agreement, between Apollo Medical Management, Inc. and ApolloMed Care Clinic, dated March
    28, 2014 (filed as an exhibit to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-26.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-26.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    No. 1 to Intercompany Revolving Loan Agreement, between Apollo Medical Management, Inc. and Maverick Medical Group Inc., dated
    March 28, 2014 (filed as an exhibit to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-27.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414020524/v373739_ex10-27.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    No. 1 to Intercompany Revolving Loan Agreement, between Apollo Medical Management, Inc. and ApolloMed Hospitalists, dated
    March 28, 2014 (filed as an exhibit to a Current Report on Form 8-K/A on April 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-47.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-47.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    of Directors Agreement dated March 7, 2012 by and between Apollo Medical Holdings, Inc., and Gary Augusta (filed as an exhibit
    to an Annual Report on Form 10-K on May 8, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-48.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414028378/v374384_ex10-48.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    of Directors Agreement dated February 15, 2012 by and between Apollo Medical Holdings, Inc., and Ted Schreck (filed as an
    exhibit to an Annual Report on Form 10-K on May 8, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414041265/v383175_ex10-01.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414041265/v383175_ex10-01.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consulting
    Agreement as of May 20, 2014&nbsp;by and between Apollo Medical Holdings, Inc. and Bridgewater Healthcare Group, LLC (filed
    as an exhibit to a Current Report on Form 8-K/A on July 3, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414056154/v389234_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.38+</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414056154/v389234_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Board
    of Directors Agreement dated May 22, 2013 by and between Apollo Medical Holdings, Inc., &nbsp;and Warren Hosseinion, M.D.
    (filed as an exhibit to a Current Report on Form 8-K on September 16, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414064307/v392764_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.39</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414064307/v392764_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contribution
    Agreement, dated as of October 27, 2014, by and among Dr. Sandeep Kapoor, M.D, Marine Metspakyan and Apollo Palliative Services
    LLC (filed as an exhibit to a Current Report on Form 8-K on October 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414064307/v392764_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.40</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414064307/v392764_ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contribution
    Agreement, dated as of October 27, 2014, by and between Rob Mikitarian and Apollo Palliative Services LLC (filed as an exhibit
    to a Current Report on Form 8-K on October 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414064307/v392764_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.41</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414064307/v392764_ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership
    Interest Purchase Agreement, entered into as of October 27, 2014, by and among Apollo Palliative Services LLC, Apollo Medical
    Holdings, Inc., Dr. Sandeep Kapoor, M.D., Marine Metspakyan and Best Choice Hospice Care, LLC (filed as an exhibit to a Current
    Report on Form 8-K on October 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414064307/v392764_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.42</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414064307/v392764_ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Purchase Agreement entered into as of October 27, 2014, by and among Apollo Palliative Services LLC, Rob Mikitarian and Holistic
    Care Home Health Agency, Inc. (filed as an exhibit to a Current Report on Form 8-K on October 31, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414068523/v393189_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.43</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414068523/v393189_ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second
    Amendment to Lease Agreement dated October 14, 2014 by and between Apollo Medical Holdings, Inc. and EOP-700 North Brand,
    LLC (filed as an exhibit on Quarterly Report on Form 10-Q on November 14, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414072756/v395966_ex10-01.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.44</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420414072756/v395966_ex10-01.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease
    Agreement, dated July 22, 2014, by and between Numen, LLC and Apollo Medical Management, Inc. (filed as an exhibit to a Current
    Report on Form 8-K/A on December 8, 2014).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415007957/v400788_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.45</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415007957/v400788_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">First
    Amendment and Acknowledgement, dated as of February 6, 2015, among Apollo Medical Holdings, Inc., NNA of Nevada, Inc., Warren
    Hosseinion, M.D. and Adrian Vazquez, M.D. (filed as an exhibit to a Current Report on Form 8-K on February 10, 2015).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415030989/v410693_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.47</FONT></A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415030989/v410693_ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
    to the First Amendment and Acknowledgement, dated as of May 13, 2015, among Apollo Medical Holdings, Inc., NNA of Nevada,
    Inc., Warren Hosseinion, M.D. and Adrian Vazquez, M.D. (filed as an exhibit to a Current Report on Form 8-K on May 15, 2015).</FONT></A></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415041939/v415252_ex10-1.htm" STYLE="-sec-extract: exhibit">10.48</A></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 90%; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415041939/v415252_ex10-1.htm" STYLE="-sec-extract: exhibit">Amendment
    to the First Amendment and Acknowledgement, dated as of July 7, 2015, among Apollo Medical Holdings, Inc., NNA of Nevada,
    Inc., Warren Hosseinion, M.D. and Adrian Vazquez, M.D. (filed as an exhibit to a Current Report on Form 8-K on July 10, 2015).&nbsp;</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415050797/v418202_ex10-49.htm" STYLE="-sec-extract: exhibit">10.49</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415050797/v418202_ex10-49.htm" STYLE="-sec-extract: exhibit">Waiver
    and Consent dated as of August 18, 2015 between Apollo Medical Holdings, Inc. and NNA of Nevada, Inc. (filed as an exhibit
    to a Quarterly Report on Form 10-Q on August 19, 2015).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415059991/v422440_ex10-1.htm" STYLE="-sec-extract: exhibit">10.50</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415059991/v422440_ex10-1.htm" STYLE="-sec-extract: exhibit">Securities
    Purchase Agreement dated October 14, 2015 between Apollo Medical Holdings, Inc. and Network Medical Management, Inc. (filed
    as an exhibit to a Current Report on Form 8-K on October 19, 2015).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415066947/v425157_ex10-1.htm" STYLE="-sec-extract: exhibit">10.51</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420415066947/v425157_ex10-1.htm" STYLE="-sec-extract: exhibit">Second
    Amendment and Conversion Agreement dated as of November 17, 2015 among Apollo Medical Holdings, Inc., NNA of Nevada, Inc.,
    Warren Hosseinion, M.D. and Adrian Vazquez, M.D. (filed as an exhibit to a Current Report on Form 8-K on November 19, 2015).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416076130/v429126_ex10-2.htm" STYLE="-sec-extract: exhibit">10.52+</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416076130/v429126_ex10-2.htm" STYLE="-sec-extract: exhibit">Board
    of Directors Agreement between Apollo Medical Holdings, Inc. and Thomas S. Lam, M.D. dated January 19, 2016 (filed as an exhibit
    to a Current Report on Form 8-K on January 19, 2016.</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416076130/v429126_ex10-5.htm" STYLE="-sec-extract: exhibit">10.55+</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416076130/v429126_ex10-5.htm" STYLE="-sec-extract: exhibit">Consulting
    Agreement dated January 12, 2016 between Apollo Medical Holdings, Inc. and Flacane Advisors, Inc. (filed as an exhibit to
    a Current Report on Form 8-K on January 19, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416076130/v429126_ex10-6.htm" STYLE="-sec-extract: exhibit">10.56</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416076130/v429126_ex10-6.htm" STYLE="-sec-extract: exhibit">Indemnification
    Agreement effective as of September 21, 2015 between Apollo Medical Holdings, Inc. and William Abbott (filed as an exhibit
    to a Current Report on Form 8-K on January 19, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416078529/v430394_ex10-1.htm" STYLE="-sec-extract: exhibit">10.57+</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416078529/v430394_ex10-1.htm" STYLE="-sec-extract: exhibit">Board
    of Directors Agreement dated January 12, 2016 between Apollo Medical Holdings, Inc. and Mark Fawcett (filed as an exhibit
    to a Current Report on Form 8-K/A on February 2, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex10-1.htm" STYLE="-sec-extract: exhibit">10.58</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416092455/v436045_ex10-1.htm" STYLE="-sec-extract: exhibit">Securities
    Purchase Agreement dated March 30, 2016 between Apollo Medical Holdings, Inc. and Network Medical Management, Inc. (filed
    as an exhibit to a Current Report on Form 8-K on April 4, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-59.htm" STYLE="-sec-extract: exhibit">10.59</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-59.htm" STYLE="-sec-extract: exhibit">2015
    Equity Incentive Plan (filed as an exhibit to an Annual Report on Form 10-K on June 29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-60.htm" STYLE="-sec-extract: exhibit">10.60</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-60.htm" STYLE="-sec-extract: exhibit">Asset
    Purchase Agreement dated January 12, 2016 among Apollo Medical Holdings, Inc., Apollo Care Connect, Inc. and Healarium, Inc.
    (filed as an exhibit to an Annual Report on Form 10-K on June 29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-61.htm" STYLE="-sec-extract: exhibit">10.61</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-61.htm" STYLE="-sec-extract: exhibit">Amendment
    No. 2 to Intercompany Revolving Loan Agreement dated March 30, 2016 between&nbsp;&nbsp;Apollo Medical Management, Inc. and
    Maverick Medical Group, Inc. (filed as an exhibit to an Annual Report on Form 10-K on June 29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-62.htm" STYLE="-sec-extract: exhibit">10.62</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-62.htm" STYLE="-sec-extract: exhibit">Amended
    and Restated Subordination Agreement between Apollo Medical Management, Inc. and Maverick Medical Group, Inc. (filed as an
    exhibit to an Annual Report on Form 10-K on June 29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110211/v443110_ex10-1.htm" STYLE="-sec-extract: exhibit">10.63</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110211/v443110_ex10-1.htm" STYLE="-sec-extract: exhibit">Stock
    Purchase Agreement dated as of March 1, 2016 by and among Robert Tracy, D.O., Inc., ApolloMed Care Clinic and Warren Hosseinion,
    M.D. as nominee for Apollo Medical Management, Inc. (filed as an exhibit to a Current Report on Form 8-K on June 28, 2016).</A></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110211/v443110_ex10-2.htm" STYLE="-sec-extract: exhibit">10.64</A></TD>
    <TD STYLE="width: 1%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 90%; text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110211/v443110_ex10-2.htm" STYLE="-sec-extract: exhibit">Non-Interest
    Bearing Secured Promissory Note dated March 1, 2016 (filed as an exhibit to a Current Report on Form 8-K on June 28, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110211/v443110_ex10-3.htm" STYLE="-sec-extract: exhibit">10.65</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110211/v443110_ex10-3.htm" STYLE="-sec-extract: exhibit">First
    Amendment to Stock Purchase Agreement and to Non-Interest Bearing Promissory Note dated as of March 1, 2016 by and among Robert
    Tracy, D.O., Inc., ApolloMed Care Clinic and Warren Hosseinion, M.D. as nominee for Apollo Medical Management, Inc. (filed
    as an exhibit to a Current Report on Form 8-K on June 28, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-66.htm" STYLE="-sec-extract: exhibit">10.66</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-66.htm" STYLE="-sec-extract: exhibit">Membership
    Interest Purchase Agreement and Release dated as of December 9, 2015 among Apollo Medical Holdings, Inc., Apollo Medical Management,
    Inc., Apollo Palliative Services LLC and Sandeep Kapoor, M.D. (filed as an exhibit to an Annual Report on Form 10-K on June
    29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-67.htm" STYLE="-sec-extract: exhibit">10.67+</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-67.htm" STYLE="-sec-extract: exhibit">Amended
    and Restated Employment Agreement made as of June 29, 2016 between Apollo Medical Management, Inc. and Warren Hosseinion,
    M.D. (filed as an exhibit to an Annual Report on Form 10-K on June 29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-68.htm" STYLE="-sec-extract: exhibit">10.68+</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-68.htm" STYLE="-sec-extract: exhibit">Amended
    and Restated Employment Agreement made as of June 29, 2016 by and between Apollo Medical Management, Inc. and Adrian Vazquez,
    M.D. (filed as an exhibit to an Annual Report on Form 10-K on June 29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-69.htm" STYLE="-sec-extract: exhibit">10.69+</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-69.htm" STYLE="-sec-extract: exhibit">Amended
    and Restated Hospitalist Participation Service Agreement made as of June 29, 2016 by and between ApolloMed Hospitalists, a
    Medical Corporation, and Warren Hosseinion, M.D. (filed as an exhibit to an Annual Report on Form 10-K on June 29, 2017).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-70.htm" STYLE="-sec-extract: exhibit">10.70+</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-70.htm" STYLE="-sec-extract: exhibit">Amended
    and Restated Hospitalist Participation Service Agreement made as of June 29, 2016 by and between ApolloMed Hospitalists, a
    Medical Corporation, and Adrian Vazquez, M.D. (filed as an exhibit to an Annual Report on Form 10-K on June 29, 2017).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-71.htm" STYLE="-sec-extract: exhibit">10.71</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex10-71.htm" STYLE="-sec-extract: exhibit">Third
    Amendment dated June 28, 2016 between Apollo Medical Holdings, Inc. and NNA of Nevada, Inc. (filed as an exhibit to an Annual
    Report on Form 10-K on June 29, 2017).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416114447/v444912_ex10-1.htm" STYLE="-sec-extract: exhibit">10.72</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416114447/v444912_ex10-1.htm" STYLE="-sec-extract: exhibit">Employment
    Agreement between Apollo Medical Management, Inc. and Mihir Shah dated July 21, 2016 (filed as an exhibit to a Current Report
    on Form 8-K on July 26, 2016).</A></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 9%"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416133045/v452465_ex10-1.htm" STYLE="-sec-extract: exhibit">10.73</A></TD>
    <TD STYLE="text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 90%"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416133045/v452465_ex10-1.htm" STYLE="-sec-extract: exhibit">Stock
    Purchase Agreement dated as of November 4, 2016 by and among BAHA Acquisition, A Medical Corporation, a California professional
    corporation; Bay Area Hospitalist Associates, A Medical Corporation, a California professional corporation; and Scott Enderby,
    D.O. (filed as an exhibit to a Current Report on Form 8-K on November 10, 2016).</A></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 9%"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416133045/v452465_ex10-2.htm" STYLE="-sec-extract: exhibit">10.74</A></TD>
    <TD STYLE="text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 90%"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416133045/v452465_ex10-2.htm" STYLE="-sec-extract: exhibit">Employment
    Agreement dated as of November 4, 2016 by and between Bay Area Hospitalist Associates, Inc., a California professional corporation,
    and Scott Enderby (filed as an exhibit to a Current Report on Form 8-K on November 10, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416133045/v452465_ex10-3.htm" STYLE="-sec-extract: exhibit">10.75</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416133045/v452465_ex10-3.htm" STYLE="-sec-extract: exhibit">Non-Competition
    Agreement dated as of November 4, 2016 by and between Bay Area Hospitalist Associates, A Medical Corporation, a California
    professional corporation, and Scott Enderby, D.O. (filed as an exhibit to a Current Report on Form 8-K on November 10, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416134062/v452674_ex10-1.htm" STYLE="-sec-extract: exhibit">10.76</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416134062/v452674_ex10-1.htm" STYLE="-sec-extract: exhibit">Intercompany
    Revolving Loan Agreement dated as of July 22, 2016 by and between Apollo Medical Management, Inc. and Bay Area Hospitalist
    Associates, a Medical Corporation (filed as an exhibit to a Quarterly Report on Form 10-Q on November 14, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416136945/v454046_ex10-1.htm" STYLE="-sec-extract: exhibit">10.77</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416136945/v454046_ex10-1.htm" STYLE="-sec-extract: exhibit">Intercompany
    Revolving Loan Agreement dated as of November 22, 2016 by and between Apollo Medical Management, Inc. and Maverick Medical
    Group, Inc. (filed as an exhibit to a Current Report on Form 8-K on November 29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416136945/v454046_ex10-2.htm" STYLE="-sec-extract: exhibit">10.78</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416136945/v454046_ex10-2.htm" STYLE="-sec-extract: exhibit">Subordination
    Agreement dated as of November 22, 2016 by and between Apollo Medical Management, Inc. and Maverick Medical Group, Inc. (filed
    as an exhibit to a Current Report on Form 8-K on November 29, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140815/v455483_ex99-1.htm" STYLE="-sec-extract: exhibit">10.79</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140815/v455483_ex99-1.htm" STYLE="-sec-extract: exhibit">Employment
    Agreement dated December 20, 2016 between Apollo Medical Management, Inc. and Gary Augusta (filed as an exhibit to a Current
    Report on Form 8-K on December 21, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140815/v455483_ex99-2.htm" STYLE="-sec-extract: exhibit">10.80</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140815/v455483_ex99-2.htm" STYLE="-sec-extract: exhibit">Employment
    Agreement dated December 20, 2016 between Apollo Medical Management, Inc. and Warren Hosseinion, M.D. (filed as an exhibit
    to a Current Report on Form 8-K on December 21, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140815/v455483_ex99-3.htm" STYLE="-sec-extract: exhibit">10.81</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140815/v455483_ex99-3.htm" STYLE="-sec-extract: exhibit">Employment
    Agreement dated December 20, 2016 between Apollo Medical Management, Inc. and Mihir Shah (filed as an exhibit to a Current
    Report on Form 8-K on December 21, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140815/v455483_ex99-4.htm" STYLE="-sec-extract: exhibit">10.82</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140815/v455483_ex99-4.htm" STYLE="-sec-extract: exhibit">Employment
    Agreement dated December 20, 2016 between Apollo Medical Management, Inc. and Adrian Vazquez, M.D. (filed as an exhibit to
    a Current Report on Form 8-K on December 21, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417003013/v456696_ex10-1.htm" STYLE="-sec-extract: exhibit">10.83</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417003013/v456696_ex10-1.htm" STYLE="-sec-extract: exhibit">Next
    Generation ACO Model Participation Agreement (filed as an exhibit to a Current Report on Form 8-K on January 20, 2017).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140899/v455563_ex99-2.htm" STYLE="-sec-extract: exhibit">10.84</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140899/v455563_ex99-2.htm" STYLE="-sec-extract: exhibit">Voting
    Agreement dated as of December 21, 2016 between Apollo Medical Holdings, Inc. and Thomas Lam, M.D.&nbsp;&nbsp;(filed as an
    exhibit to a Current Report on Form 8-K on December 22, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140899/v455563_ex99-3.htm" STYLE="-sec-extract: exhibit">10.85</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140899/v455563_ex99-3.htm" STYLE="-sec-extract: exhibit">Voting
    Agreement dated as of December 21, 2016 between Apollo Medical Holdings, Inc. and Kenneth Sim, M.D. (filed as an exhibit to
    a Current Report on Form 8-K on December 22, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140899/v455563_ex99-4.htm" STYLE="-sec-extract: exhibit">10.86</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416140899/v455563_ex99-4.htm" STYLE="-sec-extract: exhibit">Consent
    and Waiver Agreement dated as of December 21, 2016 by between Apollo Medical Holdings, Inc. and Network Medical Management,
    Inc. (filed as an exhibit to a Current Report on Form 8-K on December 22, 2016).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417007951/v459177_ex99-1.htm" STYLE="-sec-extract: exhibit">10.87</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417007951/v459177_ex99-1.htm" STYLE="-sec-extract: exhibit">Promissory
    Note dated as of January 3, 2017 between Apollo Medical Holdings, Inc. and Network Medical Management, Inc. (filed as an exhibit
    to a Current Report on Form 8-K on February 13, 2017).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417009037/v459268_ex10-1.htm" STYLE="-sec-extract: exhibit">10.88</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417009037/v459268_ex10-1.htm" STYLE="-sec-extract: exhibit">Promissory
    Note (Term Loan) issued November 17, 2016 to Liviu Chindris, M.D. in the principal amount of $400,000 (filed as an exhibit
    to a Quarterly Report on Form 10-Q on February 14, 2017).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417038981/v471850_ex10-1.htm" STYLE="-sec-extract: exhibit">10.89</A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417038981/v471850_ex10-1.htm" STYLE="-sec-extract: exhibit">Fifth
    Amendment to the Registration Rights Agreement between Apollo Medical Holdings, Inc. and NNA of Nevada, Inc., dated as of
    July 26, 2017 (filed as an exhibit to a Current Report on Form 8-K on July 28, 2017).</A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> 10.90* </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> Form
    of Stockholder Lock-Up Agreement (attached as <U>Annex D</U> to the joint proxy statement/prospectus that is a part of this
    Registration Statement). </A></TD></TR>

<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417053488/tv477411_ex10-3.htm" STYLE="-sec-extract: exhibit">10.91</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417053488/tv477411_ex10-3.htm" STYLE="-sec-extract: exhibit">Amended
    and Restated Convertible Promissory Note dated as of October 17, 2017 between Apollo Medical Holdings, Inc. and Network Medical
    Management, Inc. (filed as an exhibit to a Current Report on Form 8-K on October 20, 2017).</A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417019183/v463385_ex10-2.htm" STYLE="-sec-extract: exhibit">10.92</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417019183/v463385_ex10-2.htm" STYLE="-sec-extract: exhibit">Convertible
    Promissory Note, dated as of March 30, 2017, between Apollo Medical Holdings, Inc. and Alliance Apex LLC (filed as an exhibit
    to a Current Report on Form 8-K on April 5, 2017).</A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417053488/tv477411_ex10-2.htm" STYLE="-sec-extract: exhibit">10.93</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417053488/tv477411_ex10-2.htm" STYLE="-sec-extract: exhibit">Amendment
    to Convertible Promissory Note, dated as of October 16, 2017, between Apollo Medical Holdings, Inc. and Alliance Apex LLC
    (filed as an exhibit to a Current Report on Form 8-K on October 20, 2017).</A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417046831/v474724_ex10-1.htm" STYLE="-sec-extract: exhibit">10.94</A></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417046831/v474724_ex10-1.htm" STYLE="-sec-extract: exhibit">Amendment
    No. 1 to Intercompany Revolving Loan Agreement between Apollo Medical Management, Inc. and Maverick Medical Group, dated August
    31, 2017 (filed as an exhibit to a Current Report on Form 8-K on September 6, 2017).</A></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417046831/v474724_ex10-2.htm" STYLE="-sec-extract: exhibit">10.95</A></TD>
    <TD>&nbsp;</TD>
    <TD><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417046831/v474724_ex10-2.htm" STYLE="-sec-extract: exhibit">Amendment
    No. 1 to Subordination Agreement between Apollo Medical Management, Inc. and Maverick Medical Group, Inc., dated August 31,
    2017 (filed as an exhibit to a Current Report on Form 8-K on September 6, 2017).</A></TD></TR>



<TR>
    <TD STYLE="vertical-align: top; width: 9%; text-align: center; font-size: 10pt"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex10-96.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.96*</FONT> </A></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; font-size: 10pt"> &nbsp; </TD>
    <TD STYLE="vertical-align: bottom; width: 90%; font-size: 10pt"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex10-96.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Stock Purchase Agreement among Maverick
    Medical Group Inc., Warren Hosseinion, M.D. and APC-LSMA Designated Shareholder Medical Corporation.</FONT> </A></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 9%"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex21-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">21.1*</FONT></A></TD>
    <TD STYLE="text-align: justify; width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 90%"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420416110594/v442479_ex21-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Subsidiaries
    of Apollo Medical Holdings, Inc. (filed as an exhibit to an Annual Report on Form 10-K on June 29, 2017).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417042182/v470630_ex21-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">21.2*</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417042182/v470630_ex21-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Subsidiaries
    of Network Medical Management, Inc.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex23-1.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">23.1*&nbsp;</FONT> </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex23-1.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">Consent
    of BDO USA, LLP, Independent Registered Public Accounting Firm to Apollo Medical Holdings, Inc.</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex23-2.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">23.2*&nbsp;&nbsp;</FONT> </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex23-2.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">Consent
    of BDO USA, LLP, Independent Registered Public Accounting Firm to Network Medical Management, Inc.</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex23-3.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">23.3*&nbsp;&nbsp;</FONT> </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex23-3.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">Consent
    of DNW and Associates, Inc.</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex5-1.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">23.4*</FONT> </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_ex5-1.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">Consent of McDermott Will &amp; Emery LLP (included in Exhibit 5.1).</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="tv479112_ex8-1.htm" STYLE="-sec-extract: exhibit"> 23.5# </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="tv479112_ex8-1.htm" STYLE="-sec-extract: exhibit"> Consent of McDermott
    Will &amp; Emery LLP (included in Exhibit 8.1). </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="#a_033" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">24.1*</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="#a_033" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Power of Attorney
    (included on the signature page hereto).</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-1.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">99.1*</FONT> </A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form
    of Proxy Card for Apollo Medical Holdings, Inc.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-2.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">99.2*</FONT> </A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Form
    of Proxy Card for Network Medical Management, Inc.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">99.3*</FONT> </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">Proposed
    form of Certificate of Amendment of Certificate of Incorporation of Apollo Medical Holdings, Inc. (attached as <U>Annex E
    </U>to the joint proxy statement/prospectus that is a part of this Registration Statement).</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">99.4*</FONT> </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">Proposed
    form of Amendment to Bylaws of Apollo Medical Holdings, Inc. (attached as <U>Annex F</U> to the joint proxy statement/prospectus
    that is a part of this Registration Statement).</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">99.5*</FONT> </A></TD>
    <TD STYLE="text-align: justify"> &nbsp; </TD>
    <TD STYLE="text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">Opinion
    of Bank of America Merrill Lynch, financial advisor to Apollo Medical Holdings, Inc. (attached as <U>Annex G</U> to the joint
    proxy statement/prospectus that is a part of this Registration Statement).</FONT> </A></TD></TR>
</TABLE>


<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%; text-align: center"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">99.6*</FONT> </A></TD>
    <TD STYLE="width: 1%; text-align: justify"> &nbsp; </TD>
    <TD STYLE="width: 90%; text-align: justify"> <A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417057398/tv478834_s4a.htm" STYLE="-sec-extract: exhibit"> <FONT STYLE="font-size: 10pt">Opinion
    of Vantage Point Advisors, Inc., financial advisor to Network Medical Management, Inc. (attached as <U>Annex H</U> to the
    joint proxy statement/prospectus that is a part of this Registration Statement).</FONT> </A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-7.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">99.7*</FONT> </A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-7.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Consent
    of Michael F. Eng to serve as director of Apollo Medical Holdings, Inc.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-8.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">99.8*</FONT> </A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-8.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Consent
    of Mitchell W. Kitayama to serve as director of Apollo Medical Holdings, Inc.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-9.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">99.9*</FONT> </A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-9.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Consent
    of Kenneth Sim, M.D. to serve as director of Apollo Medical Holdings, Inc.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-10.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">99.10*</FONT> </A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417054890/tv477482_ex99-10.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Consent
    of Li Yu to serve as director of Apollo Medical Holdings, Inc.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417042182/v470630_ex99-11.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">99.11*</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417042182/v470630_ex99-11.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Consent
    of Bank of America Merrill Lynch.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417042182/v470630_ex99-12.htm" STYLE="-sec-extract: exhibit">
    <FONT STYLE="font-size: 10pt">99.12*</FONT></A></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="http://www.sec.gov/Archives/edgar/data/1083446/000114420417042182/v470630_ex99-12.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-size: 10pt">Consent
    of Vantage Point Advisors, Inc.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 9%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">*</P></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; width: 90%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Previously
filed</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">#</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">Filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"> ** </TD>
    <TD> &nbsp; </TD>
    <TD STYLE="padding-left: 0.25in; text-align: justify"> Filed by amendment </TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">+</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">Management contract or compensatory
    plan, contract or arrangement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&dagger;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-align: justify"><FONT STYLE="font-size: 10pt">The schedules and exhibits to this
    exhibit have been omitted pursuant to Item 601(b)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will
    be furnished to the SEC upon request.</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 12; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>2
<FILENAME>tv479112_ex8-1.htm
<DESCRIPTION>EXHIBIT 8.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 8.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tv479112_ex8-1img01.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Boston Brussels Chicago Dallas D&uuml;sseldorf Frankfurt Houston
London Los Angeles Miami</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Milan Munich New York Orange County Paris Rome Seoul Silicon
Valley Washington, D.C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Strategic alliance with MWE China Law Offices (Shanghai)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 9, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Apollo Medical Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">700 North Brand Boulevard</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Suite 1400</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Glendale, California 91203</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9;Apollo Medical Holdings, Inc./Network Medical Management,
Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have acted as counsel to Apollo Medical Holdings, Inc., a
Delaware corporation (&ldquo;ApolloMed&rdquo;) in connection with the merger (the &ldquo;Merger&rdquo;) of Apollo Acquisition Corp.,
a California corporation (&ldquo;Merger Sub&rdquo;) and wholly-owned subsidiary of ApolloMed, with and into Network Medical Management,
Inc., a California corporation (&ldquo;NMM&rdquo;), pursuant to an Agreement and Plan of Merger by and among ApolloMed, Merger
Sub, and NMM dated as of December 31, 2016, and amended on March 30, 2017 and October 17, 2017 (the &ldquo;Merger Agreement&rdquo;).
Capitalized terms not otherwise defined herein shall have the meanings set forth in the Merger Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In formulating this opinion, we have examined the Merger Agreement,
the Registration Statement on Form S-4 of ApolloMed (the &ldquo;Registration Statement&rdquo;), and the Proxy Statement/Prospectus
relating to the Merger Agreement included therein (the &ldquo;Proxy Statement&rdquo;), as filed with the Securities and Exchange
Commission on August 10, 2017, as amended through the date hereof, and such other documents as we deem relevant for purposes of
this opinion. In addition, we have assumed with your consent that (i) the Merger will be consummated in the manner contemplated
by the Registration Statement and the Proxy Statement and in accordance with the provisions of the Merger Agreement and none of
the terms and conditions contained therein have been or will be modified in any respect relevant to this opinion; (ii) the statements
concerning the Merger, other than those relating to the U.S. federal income tax consequences of the Merger, set forth in the Registration
Statement and the Proxy Statement, including the purposes of the parties for consummating the Merger, are true, accurate and complete
and will continue to be true, accurate and complete through and as of the Effective Time; (iii) the representations made to us
by ApolloMed, Merger Sub and NMM in connection with the Merger (in the form of representation letters dated as of the date hereof
(the &ldquo;Representation Letters&rdquo;)) and delivered to us for purposes of this opinion are true, accurate and complete and
will continue to be true, accurate and complete through and as of the Effective Time; (iv) any representation or other statement
in the Representation Letters or the other documents referred to herein made &ldquo;to the best of the knowledge&rdquo; or similarly
qualified is, and thereafter as relevant will be, in each case, correct without such qualification; (v) no actions have been (or
will be) taken that are inconsistent with any representation or other statement contained in the Representation Letters; (vi) each
of ApolloMed, Merger Sub and NMM will comply with all reporting obligations with respect to the Merger required under the Internal
Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;); (vii) the Merger Agreement constitutes the legal, valid and binding
obligation of the parties thereto and is enforceable in accordance with its terms; (viii) there are no other understandings or
agreements between or among the parties to the Merger Agreement that bear directly or indirectly on the Merger; and (ix) original
documents (including signatures) are authentic, documents submitted to us as copies conform to the original documents, and there
has been (or will be by the Effective Time) due execution and delivery of all documents where due execution and delivery are prerequisites
to the effectiveness thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Apollo Medical Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 9, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In rendering this opinion, with your permission, we have not
undertaken any independent investigation or verification of any fact or matter set forth in any documents or materials or any assumption
upon which we have relied (including, without limitation, the assumptions set forth above), and we expressly disclaim any intent,
undertaking, or obligation to make any such investigation or verification. We are not aware, however, of any material facts or
circumstances contrary to or inconsistent with any fact or matter set forth in any documents or materials or any assumption upon
which we have relied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Based upon the foregoing and subject to the exceptions, qualifications
and limitations set forth herein, we are of the opinion that (i) for United States federal income tax purposes, the Merger will
qualify as a reorganization within the meaning of Section 368(a) of the Code, and that each of ApolloMed, Merger Sub and NMM will
be a party to such reorganization within the meaning of Section 368(b) of the Code; and (ii) the discussion contained in the Proxy
Statement under the caption &ldquo;Certain Material U.S. Federal Income Tax Consequences of the Merger&rdquo; concerning the federal
income tax consequences of the Merger to the NMM shareholders, insofar as it summarizes United States federal income tax law, is
correct in all material respects as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This opinion relates solely to the United States federal income
tax consequences of the Merger and no opinion is expressed as to federal tax consequences of the Merger, other than those related
to United States federal income taxes, or the tax consequences of the Merger under any foreign, state or local tax law. This opinion
is based on current United States federal income tax law and administrative practice in effect as of the date hereof. It represents
our best legal judgment as to the matters addressed herein, but is not binding on the Internal Revenue Service (&ldquo;IRS&rdquo;)
or the courts. No ruling has been or will be sought from the IRS as to any United States federal income tax consequences of the
Merger. Accordingly, no assurance can be given that this opinion, if contested, would be sustained by a court. Furthermore, the
authorities on which we rely are subject to change either prospectively or retroactively, and any such change, or any variation
or difference in the facts from those on which we rely and assume as correct, as set forth above, might affect the conclusions
stated herein. Nevertheless, by rendering this opinion, we undertake no responsibility to advise you as to any changes or new developments
in United States federal income tax laws or the application or interpretation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Apollo Medical Holdings, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">November 9, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We hereby consent to the filing of this opinion as an exhibit
to the Registration Statement. In giving this consent, we do not hereby admit that we are within the category of persons whose
consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ McDermott Will &amp; Emery LLP</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tv479112_ex8-1img01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tv479112_ex8-1img01.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ /P"V P$1  (1 0,1 ?_$ +,   $#!0$!
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M"0&]M#;;[O)#%QMNW-L+MH#:KHXO5J $TB6&.!'=S@5N;8J]];K1?:DK3;6
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M4G/E]\?1\U%29E"QTFRD/QA,58T>]:O (8H_<F<R"B@I*%'P)!]--5C"J?\
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MQ?#K1-@8V^L.XMD]%:4>NT5HN1_N,G911<  \3[AMY --[@>16U?U*B%)"
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M!/29R$N,B8'='4?JMV<_5T*ITTZE!KJ@M]22I HU!.K#$%.J8@H@$3\E^_\
I\3F/]P_N<_> ^W/?GQY^./IMX]-9-(7)2C_:3$O:(WX62R3(RRXQ_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
